← SynDRA
BRANEBRUTINIB
SynDRA canonical compound SYN0039758 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | BTK |
| Mechanism of action | Bruton's tyrosine kinase (BTK) inhibitor |
All known targets
Mechanisms of action (all sources)
- BTK INHIBITOR
- Tyrosine-protein kinase BTK inhibitor
- Bruton's tyrosine kinase (BTK) inhibitor
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- BMS-986195
- (S)-4-(3-(2-BUTYNOYLAMINO)PIPERIDIN-1-YL)-5-FLUORO-2,3-DIMETHYL-1H-INDOLE-7-CARBOXAMIDE
- (S)-4-(3-(but-2-ynamido)piperidin-1-yl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide
- 1H-Indole-7-carboxamide, 5-fluoro-2,3-dimethyl-4-((3S)-3-((1-oxo-2-butyn-1-yl)amino)-1-piperidinyl)-
- 4-((3S)-3-(2-BUTYNOYLAMINO)-1-PIPERIDINYL)-5-FLUORO-2,3-DIMETHYL-1HINDOLE-7-CARBOXAMIDE
- 4-((3S)-3-(2-Butynoylamino)-1-piperidinyl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide
- 4-((3S)-3-(But-2-ynamido)piperidin-1-yl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide
- 4-[(3S)-3-(but-2-ynamido)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide
- 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide
- 7LBRZUYSHU
- AC-31535
- AKOS037649047
- BCP29496
- BDBM164638
- BDBM166759
- BMS986195
- Branebrutinib (BMS-986195)
- Branebrutinib (USAN)
- BRANEBRUTINIB [INN]
- Branebrutinib [USAN]
- BRANEBRUTINIB [WHO-DD]
- BS-16393
- C20H23FN4O2
- CHEMBL4297674
- CS-0043577
- D11478
- DB15347
- EN300-2007801
- EX-A2720
- Example 223 [US20160115126A1]
- GTPL9869
- HY-112161
- MFCD31631584
- NSC807627
- NSC-807627
- Q50825082
- s8832
- SCHEMBL17699728
- UNII-7LBRZUYSHU
Look up BRANEBRUTINIB in the interactive SynDRA portal →